Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Relaxo Footwears Limited
  6. Summary
    530517   INE131B01039

RELAXO FOOTWEARS LIMITED

(530517)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/18/2021 Date
1360.55 1360.4 1366.3 1351.5 1369.75 Last
70179 22079 33440 31945 14776 Volume
+3.64% -0.01% +0.43% -1.08% +1.35% Change
Estimated financial data (e)
Sales 2022 28 030 M 373 M 373 M
Net income 2022 3 084 M 41,1 M 41,1 M
Net cash position 2022 5 175 M 68,9 M 68,9 M
P/E ratio 2022 110x
Yield 2022 0,22%
Sales 2023 33 896 M 451 M 451 M
Net income 2023 4 125 M 54,9 M 54,9 M
Net cash position 2023 7 059 M 94,0 M 94,0 M
P/E ratio 2023 83,9x
Yield 2023 0,27%
Capitalization 336 B 4 465 M 4 480 M
EV / Sales 2022 11,8x
EV / Sales 2023 9,72x
Nbr of Employees 8 229
Free-Float 25,3%
More Financials
Company
Relaxo Footwears Limited is engaged in the manufacturing and trading of footwear and related products. The principal activity of the Company is the manufacture of footwear made primarily of vulcanized or molded rubber and plastic. Its brands include Hawaii, Flite, Sparx, Schoolmate, Elena, Casualz and Bahamas. Under Hawaii brand, it offers its products in various categories, such as Hi-Fashion, including HF-34,... 
Sector
Footwear
Calendar
11/01Earnings Release
More about the company
Ratings of Relaxo Footwears Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about RELAXO FOOTWEARS LIMITED
08/27Relaxo Footwears Limited Approves the Final Dividend for the Financial Year 2020-21
CI
08/01RELAXO FOOTWEARS' : Net Profit Climbs 28% in Fiscal Q1
MT
07/31Relaxo Footwears Limited Reports Earnings Results for the First Quarter Ended June 30, ..
CI
07/28Relaxo Footwears Limited Recommends Final Dividend for the Financial Year 2020-2021
CI
07/01RELAXO FOOTWEARS : ICRA Affirms AA Rating on Relaxo Footwears' Fund-Based Financing; Raise..
MT
05/20RELAXO FOOTWEARS' : Net Profit Nearly Doubles in Q4
MT
05/20Relaxo Footwears Limited Recommends Final Dividend for the Year Ended March 31, 2021
CI
05/20Relaxo Footwears Limited Reports Earnings Results for the Fourth Quarter Ended March 31..
CI
01/30Relaxo Footwears Limited Reports Earnings Results for the Third Quarter Ended December ..
CI
2020MARKET CHATTER : Relaxo Footwears Plans to Invest $20 Million for New Manufacturing Unit
MT
2020Relaxo Footwears Limited Reports Earnings Results for the Second Quarter Ended Septembe..
CI
2020Relaxo Footwears Limited Ratifies Payment of Interim Dividend for the Financial Year 20..
CI
2020Relaxo Footwears Limited Reports Earnings Results for the First Quarter Ended June 30, ..
CI
2020Relaxo Footwears Limited Reports Earnings Results for the Fourth Quarter Ended March 31..
CI
2020Relaxo Footwears Limited Decides Not to Declare Any Final Dividend for the Financial Ye..
CI
More news
News in other languages on RELAXO FOOTWEARS LIMITED

- No features available -

More news
Chart RELAXO FOOTWEARS LIMITED
Duration : Period :
Relaxo Footwears Limited Technical Analysis Chart | 530517 | INE131B01039 | MarketScreener
Technical analysis trends RELAXO FOOTWEARS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 1 369,75 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Ramesh Kumar Dua Managing Director & Executive Director
Sushil Batra Chief Financial Officer
Vikas Kumar Tak Secretary & Compliance Officer
Vivek Kumar Independent Non-Executive Director
Pankaj Shrimali Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RELAXO FOOTWEARS LIMITED68.85%4 517
PUMA SE8.58%17 392
DECKERS OUTDOOR CORPORATION28.17%10 168
CROCS, INC.128.46%8 930
DR. MARTENS PLC0.00%5 056
ALPARGATAS S.A.12.67%4 592